The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
Open accessAbstract
UNLABELLED: Activation of farnesoid X receptor (Fxr, Nr1h4) is a major mechanism in suppressing bile-acid synthesis by reducing the expression levels of genes encoding key bile-acid synthetic enzymes (e.g., cytochrome P450 [CYP]7A1/Cyp7a1 and CYP8B1/Cyp8b1). FXR-mediated induction of hepatic small heterodimer partner (SHP/Shp, Nr0b2) and intestinal fibroblast growth factor 15 (Fgf15; FGF19 in humans) has been shown to be responsible for this suppression. However, the exact contribution of Shp/Fgf15 to this suppression, and the associated cell-signaling pathway, is unclear. By using novel genetically modified mice, the current study showed that the intestinal Fxr/Fgf15 pathway was critical for suppressing both Cyp7a1 and Cyp8b1 gene expression, but the liver Fxr/Shp pathway was important for suppressing Cyp8b1 gene expression and had a minor role in suppressing Cyp7a1 gene expression. Furthermore, in vivo administration of Fgf15 protein to mice led to a strong activation of extracellular signal-related kinase (ERK) and, to a smaller degree, Jun N-terminal kinase (JNK) in the liver. In addition, deficiency of either the ERK or JNK pathway in mouse livers reduced the basal, but not the Fgf15-mediated, suppression of Cyp7a1 and Cyp8b1 gene expression. However, deficiency of both ERK and JNK pathways prevented Fgf15-mediated suppression of Cyp7a1 and Cyp8b1 gene expression. CONCLUSION: The current study clearly elucidates the underlying molecular mechanism of hepatic versus intestinal Fxr in regulating the expression of genes critical for bile-acid synthesis and hydrophobicity in the liver.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intestinal Fgf15 is a potent inhibitor of Cyp7a1 expression and BA synthesis (Kong et al., 2012).”
From Microbiota-related Changes in Bile Acid & Tryptophan Metabolism are Associated with Gastrointestinal Dysfunction in a Mouse Model of Autism (2017) · cites this paper as Kong et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Molecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-p, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 751
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 455
Molecular Regulation of Bile Acid Homeostasis
Choudhuri, S., & Klaassen, C. D. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000643 · Cited by 79
Role of bile acids in inflammatory bowel disease
Tiratterra, E. (2018) · Annals of Gastroenterology · doi:10.20524/aog.2018.0239 · Cited by 73
Wang, Y., Ding, W., & Li, T. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.04.005 · Cited by 76
Regulation of Hepatic Stellate Cells and Fibrogenesis by Fibroblast Growth Factors
Schumacher, J. D., & Guo, G. L. (2016) · BioMed Research International · doi:10.1155/2016/8323747 · Cited by 70
Zhou, S., You, H., Qiu, S., Yu, D., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113577 · Cited by 71
Shu, Y., Huang, Y., Dong, W., Fan, X., Sun, Y., Chen, G., Zeng, X., & Ye, H. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.125662 · Cited by 72
Fernandez-Rojo, M. A., Gongora, M., Fitzsimmons, R. L., Martel, N., Martin, S. D., Nixon, S. J., Brooks, A. J., Ikonomopoulou, M. P., Martin, S., Lo, H. P., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.017 · Cited by 70
Ciaula, A. D., Bonfrate, L., Baj, J., Khalil, M., Garruti, G., Stellaard, F., Wang, H. H., Wang, D. Q. ‐., & Portincasa, P. (2022) · Nutrients · doi:10.3390/nu14234950 · Cited by 76
Bile acids regulation of cellular stress responses in liver physiology and diseases
Li, T., Hasan, M. N., & Gu, L. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100074 · Cited by 75
Wang, L., Guixin, W., Wu, F., Jiang, N., & Lin, Y. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.12.022 · Cited by 67
Thompson, M. D., Moghe, A., Cornuet, P. K., Marino, R. B., Tian, J., Wang, P., Ma, X., Abrams, M. T., Locker, J. D., Monga, S. P., et al. (2017) · Hepatology · doi:10.1002/hep.29371 · Cited by 64
Review article: therapeutic bile acids and the risks for hepatotoxicity
Ashby, K., Almario, E. N., Tong, W., Borlak, J. T., Mehta, R., & Chen, M. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14678 · Cited by 66
Inflammation and Cell Death During Cholestasis: The Evolving Role of Bile Acids
Woolbright, B. L., & Jaeschke, H. (2019) · Gene Expression · doi:10.3727/105221619x15614873062730 · Cited by 73
Complex interaction between circadian rhythm and diet on bile acid homeostasis in male rats
Eggink, H. M., Oosterman, J. E., de Goede, P., de Vries, E. M., Foppen, E., Koehorst, M., Groen, A. K., Boelen, A., Romijn, J. A., la Fleur, S. E., et al. (2017) · Chronobiology International · doi:10.1080/07420528.2017.1363226 · Cited by 68
Bile Salt Hydrolase-Competent Probiotics in the Management of IBD: Unlocking the “Bile Acid Code”
Gadaleta, R. M., Cariello, M., Crudele, L., & Moschetta, A. (2022) · Nutrients · doi:10.3390/nu14153212 · Cited by 67
Schumacher, J. D., & Guo, G. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_228 · Cited by 64
Mencarelli, A., Renga, B., D’Amore, C., Santorelli, C., Graziosi, L., Bruno, A. M., Monti, M. C., Distrutti, E., Cipriani, S., Donini, A., et al. (2013) · Diabetes · doi:10.2337/db13-0299 · Cited by 67
Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile salts
Delmas, J., Gibold, L., Faïs, T., Batista, S., Leremboure, M., Sinel, C., Vazeille, E., Cattoir, V., Buisson, A., Barnich, N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38628-1 · Cited by 63
Bile acids and their effects on diabetes
Rajani, C., & Jia, W. P. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0644-x · Cited by 61
Mechanisms of enterohepatic fibroblast growth factor 15/19 signaling in health and disease
Jahn, D., Rau, M., Hermanns, H. M., & Geier, A. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.016 · Cited by 65
Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport
Xie, C., Takahashi, S., Brocker, C. N., He, S., Chen, L., Xie, G., Jang, K., Gao, X., Krausz, K. W., Qu, A., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.05.014 · Cited by 63
Zhan, L., Liu, H.-X., Fang, Y., Kong, B., He, Y.-Q., Zhong, X.-B., Fang, J.-W., Wan, Y., & Guo, G. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105930 · Cited by 62
RNA-binding protein ZFP36L1 maintains posttranscriptional regulation of bile acid metabolism
Tarling, E. J., Clifford, B. L., Cheng, J., Morand, P., Cheng, A., Lester, E., Sallam, T., Turner, M., & Vallim, T. Q. D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94029 · Cited by 59
AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle
Kim, Y., Seok, S., Byun, S., Kong, B., Zhang, Y., Guo, G. L., Xie, W., Ma, J., KEMPER, B. W., & Kemper, J. K. (2018) · Nature Communications · doi:10.1038/s41467-018-03060-y · Cited by 59
Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice
Fu, Z. D., & Klaassen, C. D. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.10.020 · Cited by 59
Garcia, M., Thirouard, L., Sèdes, L., Monrose, M., Holota, H., Caira, F., Volle, D. H., & Beaudoin, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113630 · Cited by 58
Zhai, Y., Zhou, W., Yan, X., Qiao, Y., Guan, L., Zhang, Z., Liu, H., Jiang, J., Liu, J., & Peng, L. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154444 · Cited by 54
Pang, J., Raka, F., Heirali, A., Shao, W., Liu, D., Gu, J., Feng, J. N., Mineo, C., Shaul, P. W., Qian, X., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38259-1 · Cited by 58
Lin, S., Yang, X., Yuan, P., Yang, J., Wang, P., Zhong, H., Zhang, X., Che, L., Feng, B., Li, J., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01332 · Cited by 55
Zhang, J., Gupte, J., Gong, Y., Weiszmann, J., Zhang, Y., Lee, K. J., Richards, W. G., & Li, Y. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2016.12.016 · Cited by 54
Aflatoxin B1 induces liver injury by disturbing gut microbiota-bile acid-FXR axis in mice
Liu, Y., Li, J., Kang, W., Liu, S., Liu, J., Shi, M., Wang, Y., Liu, X., Chen, X., & Huang, K. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.113751 · Cited by 54
Remote Sensing Between Liver and Intestine: Importance of Microbial Metabolites
Fu, Z. D., & Cui, J. Y. (2017) · Current Pharmacology Reports · doi:10.1007/s40495-017-0087-0 · Cited by 54
SRT1720 Alleviates ANIT-Induced Cholestasis in a Mouse Model
Yu, L., Liu, X., Yuan, Z., Li, X., Yang, H., Yuan, Z., Sun, L., Zhang, L., & Jiang, Z. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00256 · Cited by 55
Gadaleta, R. M., Scialpi, N., Peres, C. M., Cariello, M., Ko, B., Luo, J., Porru, E., Roda, A., Sabbà, C., & Moschetta, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-35496-z · Cited by 54
Duan, Y., Zhang, F., Yuan, W., Wei, Y., Wei, M., Zhou, Y., Yang, Y., Chang, Y., & Wu, X. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116638 · Cited by 55
Schumacher, J. D., Kong, B., Pan, Y., Zhan, L., Sun, R., Aa, J., Rizzolo, D., Richardson, J. R., Chen, A., Goedken, M., et al. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.06.023 · Cited by 53
Kong, B., Sun, R., Huang, M., Chow, M. D., Zhong, X., Xie, W., Lee, Y., & Guo, G. L. (2018) · Hepatology · doi:10.1002/hep.30041 · Cited by 52
Self-citationFXR Primes the Liver for Intestinal FGF15 Signaling by Transient Induction of β-Klotho
Fu, T., Kim, Y., Byun, S., Kim, D.-H., Seok, S., Suino-Powell, K. M., Xu, H. E., KEMPER, B. W., & Kemper, J. K. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1226 · Cited by 53
Tsuchiya, H., da Costa, K.-A., Lee, S., Renga, B., Jaeschke, H., Yang, Z., Orena, S., Goedken, M. J., Zhang, Y., Kong, B., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.045 · Cited by 51
Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications
Álvarez‐Sola, G., Uriarte, I., Latasa, M. U., Jiménez, M., Bárcena‐Varela, M., Santamaría, E., Urtasun, R., Rodríguez‐Ortigosa, C. M., Prìeto, J., Berraondo, P., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.025 · Cited by 54
Wang, Y., Zhang, H., Jiang, J.-M., Zheng, D., Chen, Y., Wan, S.-J., Tan, H., Tang, L., & Xu, H. (2018) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.12.047 · Cited by 51
Kong, B., & Guo, G. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085890 · Cited by 50
Zhu, R., Sun, Y., Hou, Y., Fan, J., Chen, G., & Li, T. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.018 · Cited by 51
Mukherjee, A. G., Wanjari, U. R., Kannampuzha, S., Murali, R., Namachivayam, A., Ganesan, R., Dey, A., Babu, A., Renu, K., Vellingiri, B., et al. (2023) · Metabolites · doi:10.3390/metabo13010129 · Cited by 56
Xiang, D., Yang, J., Liu, L., Yu, H., Gong, X., & Liu, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115606 · Cited by 51
Kong, B., Zhu, Y., Li, G., Williams, J. A. R., Buckley, K., Tawfik, O. W., Luyendyk, J. P., & Guo, G. L. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00134.2015 · Cited by 50
Endoplasmic Reticulum Stress Regulates Hepatic Bile Acid Metabolism in Mice
Henkel, A. S., LeCuyer, B. E., Olivares, S., & Green, R. M. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.11.006 · Cited by 47
Hu, T., Song, J., Zeng, W.-Y., Li, J., Wang, H., Zhang, Y., & Suo, H. (2020) · Food and Chemical Toxicology · doi:10.1016/j.fct.2020.111533 · Cited by 48
Dark and bright side of targeting fibroblast growth factor receptor 4 in the liver
Gadaleta, R. M., & Moschetta, A. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.029 · Cited by 47
Zhu, L., Wang, L., Cao, F., Liu, P., Bao, H., Yan, Y., Dong, X., Wang, D., Wang, Z., & Gong, P. (2018) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.537 · Cited by 47
Liu, X., Guo, G. L., Kong, B., Hilburn, D. B., Hubchak, S. C., Park, S., LeCuyer, B. E., Hsieh, A., Wang, L., Fang, D., et al. (2018) · Hepatology · doi:10.1002/hep.29815 · Cited by 46
Metabolic Effects of Bile Acids: Potential Role in Bariatric Surgery
Flynn, C. R., Albaugh, V. L., & Abumrad, N. N. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.014 · Cited by 48
Ding, L., Pang, S., Sun, Y., Tian, Y., Li, Y., & Dang, N. (2014) · International Journal of Endocrinology · doi:10.1155/2014/751859 · Cited by 45
Cariello, M., Peres, C., Zerlotin, R., Porru, E., Sabbà, C., Roda, A., & Moschetta, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-11549-7 · Cited by 39
Meng, Q., Chen, X., Wang, C., Liu, Q., Sun, H., Sun, P., Huo, X., Liu, Z., Yao, J., & Liu, K. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1727-x · Cited by 44
Deng, Z., Meng, C., Huang, H., Song, S., Fu, L., & Fu, Z. (2022) · Food & Function · doi:10.1039/d2fo01161a · Cited by 45
Role of Nuclear Receptors in Lipid Dysfunction and Obesity-Related Diseases
Swanson, H. I., Wada, T., Xie, W., Renga, B., Zampella, A., Distrutti, E., Fiorucci, S., Kong, B., Thomas, A., Guo, G. L., et al. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.048694 · Cited by 45
The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism
Lefort, C., & Cani, P. D. (2021) · Cells · doi:10.3390/cells10020400 · Cited by 44
Liu, Y., Kang, W., Liu, S., Li, J., Liu, J., Chen, X., Gan, F., & Huang, K. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.157861 · Cited by 46
Xiao, Y., Wang, Y., Liu, Y., Wang, W., Tian, X., Chen, S., Lu, Y., Du, J., & Cai, W. (2021) · Liver International · doi:10.1111/liv.14906 · Cited by 43
Toxic effects of triphenyltin on the development of zebrafish (Danio rerio) embryos
Qiao, Y., Zhou, Y., Zhang, X., Faulkner, S., Liu, H., & Wang, L. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.163783 · Cited by 42
Enhanced Alcoholic Liver Disease in Mice with Intestine-specific Farnesoid X Receptor Deficiency
Huang, M.-X., Kong, B., Zhang, M., Rizzolo, D., Armstrong, L. E., Schumacher, J. D., Chow, M. D., Lee, Y.-H., Joseph, L., Stofan, M., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0439-y · Cited by 40
Gardès, C., Chaput, E., Staempfli, A. A., Blum, D., Richter, H. G., & Benson, G. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m033423 · Cited by 42
Miyazaki, T., Honda, A., Ikegami, T., Iwamoto, J., Monma, T., Hirayama, T. T., Saito, Y., Yamashita, K., & Matsuzaki, Y. (2015) · SpringerPlus · doi:10.1186/s40064-015-1304-0 · Cited by 41
The adipokine Retnla modulates cholesterol homeostasis in hyperlipidemic mice
Lee, M., Lim, C.-J., Lee, Y.-H., Park, J., Sonn, S. K., Lee, M.-N., Jung, I., Jeong, S., Jeon, S., Lee, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5410 · Cited by 44
Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis
Milkiewicz, M., Klak, M., Kempińska‐Podhorodecka, A., Wiechowska–Kozłowska, A., Urasińska, E., Blatkiewicz, M., Wunsch, E., Elias, E., & Milkiewicz, P. (2016) · Scientific Reports · doi:10.1038/srep39573 · Cited by 41
The Role of FGF19 and MALRD1 in Enterohepatic Bile Acid Signaling
Wang, L. X., Frey, M. R., & Kohli, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.799648 · Cited by 42
Zhou, W., & Anakk, S. (2022) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2022.111616 · Cited by 42
Wei, D., Li, Y., Che, M., Li, C., Wu, Q., & Sun, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04412-0 · Cited by 41
Li, H., Xi, Y., Xin, X., Tian, H., & Hu, Y. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00454-y · Cited by 40
Zhuang, Q., Ye, X., Shen, S., Cheng, J., Shi, Y., Wu, S., Xia, J. L., Ning, M., Dong, Z., & Wan, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.701003 · Cited by 39
Bile Acid Metabolism in Health and Disease
Li, T., & Chiang, J. Y. L. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch23 · Cited by 40
Meng, Q., Chen, X., Wang, C., Liu, Q., Sun, H., Sun, P., Huo, X., Liu, Z., & Liu, K. (2015) · Food & Function · doi:10.1039/c5fo00082c · Cited by 39
Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment
Zaborska, K. E., & Cummings, B. P. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1092-3 · Cited by 40
The improvements of functional ingredients from marine foods in lipid metabolism
Wang, T., Xue, C., Zhang, T., & Wang, Y. (2018) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2018.09.004 · Cited by 39
Jiang, Y., Fu, C., Liu, G., Guo, J., & Su, Z. (2018) · Food & Nutrition Research · doi:10.29219/fnr.v62.1446 · Cited by 38
Xiang, D., Yang, J., Liu, Y., He, W., Zhang, S., Li, X., Zhang, C., & Liu, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00048 · Cited by 36
Advances in understanding the regulatory mechanism of cholesterol 7α-hydroxylase.
Ge, M.-X., Shao, R., & He, H.-W. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.008 · Cited by 34
Roessler, J., Leistner, D. M., Landmesser, U., & Haghikia, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.08.018 · Cited by 39
Obeticholic Acid and Other Farnesoid-X-Receptor (FXR) Agonists in the Treatment of Liver Disorders
Fiorucci, S., Urbani, G., Distrutti, E., & Biagioli, M. (2025) · Pharmaceuticals · doi:10.3390/ph18091424 · Cited by 42
Cao, Y. L., Xiao, Y., Zhou, K., Yan, J., Wang, P., Yan, W., & Cai, W. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00356.2017 · Cited by 38
Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions
Wei, M., Tu, W., & Huang, G. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1341938 · Cited by 39
Kim, Y., Byun, S., Zhang, Y., Seok, S., KEMPER, B. W., Ma, J., & Kemper, J. K. (2015) · Genome biology · doi:10.1186/s13059-015-0835-6 · Cited by 36
Bile Formation and the Enterohepatic Circulation
Dawson, P. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00041-4 · Cited by 36
Ge, M., Niu, W., Ren, J., Cai, S., Yu, D., Liu, H., Zhang, N., Zhang, Y., Wang, Y., Shao, R., et al. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0195-3 · Cited by 35
Thøgersen, R., Rasmussen, M. K., Sundekilde, U. K., Goethals, S., HECKE, T. V., Vossen, E., SMET, S. D., & Bertram, H. C. (2020) · Metabolites · doi:10.3390/metabo10020057 · Cited by 35
FXR and NASH: an avenue for tissue-specific regulation
Henry, Z. R., Meadows, V., & Guo, G. L. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000127 · Cited by 38
Lu, Y., Zheng, W., Lin, S., Guo, F., Zhu, Y., Wei, Y., Liu, X., Jin, S., Jin, L., & Li, Y. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.109900 · Cited by 35
de Haan, L. R., van der Lely, S. J., Warps, A. K., Hofsink, Q., Olthof, P. B., de Keijzer, M. J., Lionarons, D. A., Dias, L. M., Bruinsma, B. G., Uygun, K., et al. (2018) · Journal of Clinical and Translational Research · doi:10.18053/jctres.04.201801.001 · Cited by 33
Wang, X., Tan, Z., Chen, S., Gui, L., Li, X., Ke, D., Hou, L., & Leung, J. Y. S. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.130049 · Cited by 34
Transhepatic bile acid kinetics in pigs and humans
Eggink, H. M., van Nierop, F. S., Schooneman, M. G., Boelen, A., Kalsbeek, A., Koehorst, M., Have, G. A. M. T., de Brauw, L. M., Groen, A. K., Romijn, J. A., et al. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.06.015 · Cited by 36
Lim, J. Y., Liu, C., Hu, K., Smith, D. E., & Wang, X. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.07.007 · Cited by 34
Lv, W., Huang, J.-Y., Lin, J., Ma, Y., He, S.-Q., Zhang, Y., Wang, T.-Z., Cheng, K., Xiong, Y., Sun, F., et al. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/6409385 · Cited by 36
Zhang, L., Shi, J., Shen, Q., Fu, Y., Qi, S., Wu, J., Chen, J., Zhang, H., Mu, Y., Chen, G., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116833 · Cited by 35
Bile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa
Distrutti, E., Santucci, L., Cipriani, S., Renga, B., Schiaroli, E., Ricci, P., Donini, A., & Fiorucci, S. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1041-8 · Cited by 33
Mechanisms of STAT3 activation in the liver of FXR knockout mice
Li, G., Zhu, Y., Tawfik, O. W., Kong, B., Williams, J. A. R., Zhan, L., Kassel, K. M., Luyendyk, J. P., Wang, L., & Guo, G. L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00155.2013 · Cited by 36
Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism
Lefort, C., Roumain, M., Hul, M. V., Rastelli, M., Manco, R., Leclercq, I. A., Delzenne, N. M., Marzo, V. D., Flamand, N., Luquet, S. H., et al. (2020) · Cells · doi:10.3390/cells9051247 · Cited by 33
Liver’s influence on the brain through the action of bile acids
Yeo, X. Y., Tan, L. Y., Chae, W. R., Lee, D., Lee, Y., Wüestefeld, T., & Jung, S. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1123967 · Cited by 35
Nonalcoholic Fatty Liver Disease and Reduced Serum Vitamin D 3 Levels
Targher, G., Scorletti, E., Mantovani, A., & Byrne, C. D. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0044 · Cited by 32
Lan, T., Haywood, J., & Dawson, P. A. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.05.017 · Cited by 32
Metadata
- Authors
- Kong, B., Wang, L., Chiang, J. Y. L., Zhang, Y., Klaassen, C. D., & Guo, G. L.
- Affiliations
- University of Kansas Medical Center (US)
- University of Utah (US)
- Northeast Ohio Medical University (US)
- Corresponding author
- Guo, Grace L.
- Venue
- Hepatology
- Published
- 2012-09
- Volume
- 56
- Issue
- 3
- Pages
- 1034-1043
- ISSN
- 0270-9139 (ISSN-L)
- PMC
- PMC3390456
- OpenAlex
- W2046811888
- Cited by
- 456
- References
- 33
- Citations by year
- 2026: 31 · 2025: 36 · 2024: 34 · 2023: 51 · 2022: 41 · 2021: 37 · 2020: 30 · 2019: 28 · 2018: 36 · 2017: 33 · 2016: 25 · 2015: 24 · 2014: 28 · 2013: 16 · 2012: 5
- FWCI
- 11.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01dk044442-26)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK080440, DK-081343, R56DK090036, R01-DK-044442, R01DK081343, R01DK44442, R37DK058379)
- National Center for Research Resources (P20RR021940)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- farnesoid X receptor, bile acid synthesis, CYP7A1, CYP8B1, small heterodimer partner, FGF15, FGF19, ERK signaling, JNK signaling, tissue-specific gene regulation
- MeSH terms
- Receptor, Farnesoid X-Activated, Animals, Bile Acids and Salts, Gene Expression, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
